======= ATXN2L ======= == Gene Information == * **Official Symbol**: ATXN2L * **Official Name**: ataxin 2 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11273|11273]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WWM7|Q8WWM7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ATXN2L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ATXN2L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607931|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |LsmAD| |regulation of cytoplasmic mRNA processing body assembly| |stress granule assembly| |cytoplasmic stress granule| |regulation of organelle assembly| |ribonucleoprotein complex assembly| |ribonucleoprotein complex subunit organization| |cadherin binding| |nuclear speck| |regulation of protein complex assembly| |ribonucleoprotein complex biogenesis| |organelle assembly| |cellular protein-containing complex assembly| |regulation of cellular component biogenesis| |regulation of organelle organization| |RNA binding| |protein-containing complex assembly| |protein-containing complex subunit organization| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-2.58| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-2.5| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.39| |[[:results:exp20|Etoposide 10μM R00 exp20]]|-2.02| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|-1.92| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-1.9| |[[:results:exp83|Trametinib 10μM R02 exp83]]|-1.86| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-1.83| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.72| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|1.71| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|1.72| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|1.74| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|1.81| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.86| |[[:results:exp494|Isoniazid 100μM R08 exp494]]|1.89| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|1.9| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.93| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|2.07| |[[:results:exp139|Nicotinamide Riboside 100μM R03 exp139]]|2.11| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|2.23| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.24| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|2.37| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|2.47| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.65| |[[:results:exp518|RK-33 8μM R08 exp518]]|2.86| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|4.1| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|5.35| ^Gene^Correlation^ |[[:human genes:l:lsm12|LSM12]]|0.665| |[[:human genes:c:cdk6|CDK6]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1950 * **Expression level (log2 read counts)**: 8.15 {{:chemogenomics:nalm6 dist.png?nolink |}}